Skip to content

Drug interactions

Fostamatinib + Mitoxantrone

Severity: Moderate

Fostamatinib and Mitoxantrone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fostamatinib's active metabolite inhibits BCRP and can increase exposure to BCRP substrates such as mitoxantrone. This may worsen myelosuppression and cardiotoxicity.

What this interaction means in plain words

Fostamatinib and Mitoxantrone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fostamatinib belongs to Oncology; Mitoxantrone belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Inhibition of BCRP efflux transport by the active metabolite of fostamatinib reduces mitoxantrone clearance.

What to do

Monitor blood counts and consider reducing the mitoxantrone dose if toxicity appears.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fostamatinib and Mitoxantrone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fostamatinib with Mitoxantrone?

MediHelp rates the interaction as moderate. Fostamatinib and Mitoxantrone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fostamatinib's active metabolite inhibits BCRP and can increase exposure to BCRP substrates such as mitoxantrone. This may worsen myelosuppression and cardiotoxicity.

How serious is the interaction between Fostamatinib and Mitoxantrone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and consider reducing the mitoxantrone dose if toxicity appears.

What other medicines interact with Mitoxantrone?

MediHelp also lists interactions of Mitoxantrone with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Belatacept. The full list is on the Mitoxantrone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in